Tropicamide (torpidamine) is an artificially synthesized anticholinergic drug, and its chemical structure belongs to the derivative of the scopolamine alkaloid. As a non-selective muscarinic acetylcholine receptor antagonist, it blocks the M receptors on the iris sphincter and ciliary muscle, inhibiting the cholinergic neurotransmission, thereby causing pupil dilation (mydriasis) and ciliary muscle paralysis (accommodation paralysis). This mechanism of action makes it an indispensable mydriatic drug in ophthalmic examinations.
|
|
|
|
|
|
|
|
Core Mechanism Analysis
Pupil Dilation Effect
When Tropicamide is instilled into the conjunctival sac, the drug rapidly penetrates the cornea and enters the anterior chamber, binding to the M receptors on the iris sphincter. By blocking the agonistic effect of acetylcholine, it inhibits muscle fiber contraction, causing the pupil dilation muscle to predominate, and the pupil diameter expands to 6-8mm within 15-30 minutes, lasting for 4-8 hours. This rapid mydriatic effect provides a clear field of vision for fundus examination.
Ciliary Muscle Paralysis Effect
The drug simultaneously acts on the M receptors of the ciliary muscle, blocking the contraction regulation of the ciliary muscle by cholinergic nerves. At a 1% concentration, it can completely inhibit ciliary muscle contraction, causing the lens suspensory ligament to relax, the lens to become thinner, and thus eliminating the accommodative tension. This accommodative paralysis state is crucial for accurately measuring refractive power and differentiating true myopia from pseudo-myopia.
Neurotransmitter Block Mechanism
From a molecular perspective, Tropicamide acts as a competitive antagonist, competing with acetylcholine for binding to the M receptors, but cannot activate the downstream signaling pathway of the receptors. This blocking effect is reversible, and the receptor function naturally recovers after drug metabolism, ensuring the safety of the medication.
Clinical Application Expansion
Gold Standard for Fundus Examination
In direct ophthalmoscopy, indirect ophthalmoscopy, or anterior segment ophthalmoscopy, after pupil dilation, the expansion of pupil diameter enables the doctor to observe the peripheral retina, detect early lesions such as retinal holes and degenerative areas. It is irreplaceable for the screening of diabetic retinopathy, retinal detachment, etc.
Precise Guarantee for Refractive Examination
Before retinoscopy or computerized refraction, using pupil dilation can eliminate the influence of accommodative spasm on the refractive result. Especially for young patients with myopia, after pupil dilation, it can accurately distinguish true myopia from accommodative myopia, avoiding overcorrection. Clinical data shows that the average reduction in refraction degree after pupil dilation is 0.75D - 1.25D.
Pr-and Post-Surgery Essential Treatment
Before cataract surgery, pupil dilation ensures that the pupil is fully dilated, facilitating continuous circular capsulorhexis and phacoemulsification operations. Post-surgery, short-term use can prevent posterior iris adhesion. Before laser corneal refractive surgery, pupil dilation can accurately locate the treatment area and reduce complications caused by pupil contraction during the operation.
Special Examination Auxiliary Tools
In fluorescein fundus angiography (FFA), pupil dilation ensures that the contrast agent fully displays the morphology of retinal vessels; in ultrasound biomicroscopy (UBM) examination, a large pupil can avoid iris obstruction and clearly display the ciliary body structure.
Pharmacokinetic Characteristics
Absorption and Distribution
After administration via the conjunctival sac, the drug is rapidly absorbed through the cornea, and the concentration in the anterior chamber reaches its peak within 5-15 minutes. Due to the corneal barrier effect, systemic absorption is minimal, and the blood drug concentration is usually below the detection limit.
Metabolism and Excretion
Mainly metabolized by the liver, the metabolites are excreted through the kidneys. The half-life is approximately 2-3 hours, which explains the shorter duration of action (4-8 hours) compared to long-acting mydriatics such as atropine (3-7 days).
Concentration-Effect Relationship
0.5% concentration mainly produces mydriatic effect, lasting for 4-6 hours; 1% concentration has both strong mydriatic and complete ciliary muscle paralysis effects, lasting for 6-8 hours. The clinical choice should be based on the examination requirements.
Adverse Reactions and Treatment Strategies
Common Local Reactions
Eye Irritation: Approximately 15% of patients report a transient burning sensation, related to the pH value of the drug (4.5-5.8). It is recommended to gently press the lacrimal sac area for 2 minutes after instillation to reduce systemic absorption.
Photophobia: After pupil dilation, the expansion of the pupil diameter leads to an increase in the amount of light entering the eye, and outdoor activities require wearing tinted glasses or sunglasses.
Near Vision Blurring: Ciliary muscle paralysis causes the loss of accommodation function, lasting for 4-6 hours. Inform patients to avoid close-up use of the eyes.
Rare Systemic Reactions
In rare cases (<0.1%), the drug may be absorbed through the nasolacrimal duct and enter the nasal cavity, causing systemic symptoms such as dry mouth and tachycardia. Special attention should be paid when administering medication to children.
Contraindications and cautious usage situations
Angle-closure glaucoma: Pupil dilation may trigger an acute attack. Eye pressure must be measured before administration.
Congenital heart disease: The heart function of pediatric patients needs to be evaluated to avoid potential heart rate effects.
Allergic reactions to drug components: Allergic reactions such as conjunctival congestion and eyelid edema require immediate discontinuation of the medication.
Usage methods and precautions
Standard operating procedures
The patient lies on their back, gently pulls down the eyelid, and drops 1-2 drops of the medication (0.5% or 1% concentration). Close the eyes for 2-3 minutes after instillation, and press the lacrimal sac area with a cotton ball to reduce systemic absorption. The medication can be repeated every 5-10 minutes, but not more than 4 times within 24 hours.
Concentration selection basis
0.5% concentration: Suitable for rapid pupil dilation for examination (such as fundus photography), with quick onset (15-20 minutes) and short duration (4-6 hours).
1% concentration: Used for refractive examinations requiring complete ciliary muscle paralysis, with slower onset (25-30 minutes) and stronger effect (6-8 hours).
Adjustment for special populations
Children: The dosage should be adjusted according to age. Children under 3 years old should be cautious when using 1% concentration.
The elderly: Pay attention to the additive effect of combined medications (such as anticholinergic drugs).
Pregnant women: FDA classification is C, use only when clearly necessary.
Drug interaction warnings
Local medication synergy
Combining with mydriatic agents such as epinephrine may cause fluctuations in eye pressure. Administer the medication at least 10 minutes apart.
Systemic medication effects
Using anticholinergic drugs (such as tricyclic antidepressants) simultaneously may enhance the pupil dilation effect and cause prolonged near vision blurriness.
Contact lens wearers
Soft contact lenses should be removed before instillation. Rigid gas-permeable contact lenses (RGP) can be worn immediately after instillation, but the condition of corneal edema should be monitored.
Eight.
Clinical research progress
New formulation development
Research focuses on gel formulations with extended duration and reduced irritation. A phase III clinical trial showed that 0.5% Tropicamide gel can prolong the pupil dilation duration to 10 hours.
Exploration of combined medication
Combining with α receptor agonists (such as bromomonidine) can shorten the onset time and reduce systemic absorption. Preliminary data show that the combined regimen can shorten the pupil dilation time to 10 minutes.
Application for special populations
For patients with diabetic retinopathy, studies have confirmed that pupil dilation examination does not aggravate retinal lesions. For children's myopia prevention and control, pupil dilation examination combined with ciliary muscle paralysis can improve diagnostic accuracy.